TRPC3 over-activation might manifest in the disturbance of the cellular metabolism in pancreatic tumors, but a functional test with genetically engineered PAAD cells to establish isogenic TRPC3 activation conditions similar as performed previously are needed to test this hypothesis [30]. Here, TRPC3 is linked to pancreatic neoplasm.